875 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 18 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
OTOSOtospiralinPredicted secreted proteins
Tissue enriched
OVCH2Ovochymase 2 (gene/pseudogene)Predicted secreted proteins
Tissue enriched
OVGP1Oviductal glycoprotein 1Plasma proteins
Predicted secreted proteins
Tissue enriched
OXCT23-oxoacid CoA-transferase 2Enzymes
Predicted secreted proteins
Tissue enriched
OXTOxytocin/neurophysin I prepropeptidePlasma proteins
Predicted secreted proteins
Tissue enhanced
P3H1Prolyl 3-hydroxylase 1Disease related genes
Enzymes
Potential drug targets
Predicted secreted proteins
Nucleoli
Vesicles
Tissue enhanced
P3H3Prolyl 3-hydroxylase 3Enzymes
Predicted secreted proteins
Nucleoli
Plasma membrane
Cytosol
Tissue enhanced
P4HA3Prolyl 4-hydroxylase subunit alpha 3Enzymes
Predicted secreted proteins
Tissue enhanced
PAPPAPappalysin 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
Plasma proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enriched
PATE1Prostate and testis expressed 1Predicted secreted proteins
Tissue enriched
PATE2Prostate and testis expressed 2Predicted secreted proteins
Tissue enriched
PATE3Prostate and testis expressed 3Predicted secreted proteins
Tissue enriched
PATE4Prostate and testis expressed 4Predicted secreted proteins
Tissue enriched
PCOLCEProcollagen C-endopeptidase enhancerPlasma proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Tissue enhanced
PCOLCE2Procollagen C-endopeptidase enhancer 2Predicted secreted proteins
Nucleoplasm
Cytosol
Tissue enhanced
PCSK1NProprotein convertase subtilisin/kexin type 1 inhibitorPredicted secreted proteins
VesiclesTissue enhanced
PCSK9Proprotein convertase subtilisin/kexin type 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
PDGFCPlatelet derived growth factor CPredicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Tissue enhanced
PDILTProtein disulfide isomerase like, testis expressedPredicted secreted proteins
Tissue enriched
PDYNProdynorphinDisease related genes
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enriched
PENKProenkephalinPlasma proteins
Predicted secreted proteins
Transporters
Group enriched
PF4Platelet factor 4Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins
Group enriched
PF4V1Platelet factor 4 variant 1Plasma proteins
Predicted secreted proteins
Tissue enhanced
PGFPlacental growth factorCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleoplasm
Mitochondria
Cytosol
Tissue enhanced
PGLYRP1Peptidoglycan recognition protein 1Plasma proteins
Predicted secreted proteins
Tissue enriched
PGLYRP3Peptidoglycan recognition protein 3Predicted secreted proteins
Group enriched
PGLYRP4Peptidoglycan recognition protein 4Predicted secreted proteins
Vesicles
Plasma membrane
Group enriched
PI15Peptidase inhibitor 15Predicted secreted proteins
Vesicles
Cytosol
Tissue enhanced
PI3Peptidase inhibitor 3Plasma proteins
Predicted secreted proteins
Plasma membraneGroup enriched
PIPProlactin induced proteinPlasma proteins
Predicted secreted proteins
Group enriched
PLA2G10Phospholipase A2 group XEnzymes
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G12BPhospholipase A2 group XIIBPlasma proteins
Predicted secreted proteins
RAS pathway related proteins
VesiclesGroup enriched
PLA2G2APhospholipase A2 group IIAEnzymes
FDA approved drug targets
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Nucleoli
Tissue enhanced
PLA2G2CPhospholipase A2 group IICPredicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G2DPhospholipase A2 group IIDEnzymes
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G2EPhospholipase A2 group IIEEnzymes
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
PLA2G3Phospholipase A2 group IIIEnzymes
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLA2G5Phospholipase A2 group VDisease related genes
Enzymes
Potential drug targets
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
PLAC1Placenta specific 1Predicted secreted proteins
Tissue enriched
PLATPlasminogen activator, tissue typeCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Actin filamentsTissue enriched
PLGPlasminogenCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enriched
PLGLB1Plasminogen-like B1Predicted secreted proteins
VesiclesTissue enriched
PLGLB2Plasminogen-like B2Predicted secreted proteins
VesiclesTissue enriched
PM20D1Peptidase M20 domain containing 1Enzymes
Predicted secreted proteins
Tissue enhanced
PMCHPro-melanin concentrating hormonePredicted secreted proteins
Tissue enhanced
PNLIPPancreatic lipaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
PNLIPRP1Pancreatic lipase related protein 1Predicted secreted proteins
Tissue enriched
PNLIPRP3Pancreatic lipase related protein 3Enzymes
Predicted secreted proteins
Tissue enhanced
POMCProopiomelanocortinCancer-related genes
Disease related genes
Predicted secreted proteins
Tissue enhanced
PON1Paraoxonase 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Transporters
Tissue enriched
« prev | Page of 18 | next »